HPV

2022 - 5 - 31

Post cover
Image courtesy of "The Conversation AU"

What are HeLa cells? A cancer biologist explains (The Conversation AU)

The immortal cancer cells of Henrietta Lacks revolutionized the fields of science, medicine and bioethics. And they still survive today, more than 70 years ...

After Lacks was infected with HPV 18, the second-most-common high-risk type of the virus, her cervical cells lost the ability to produce these sentinels. Lacks didn’t know that cells in her cervix were infected with a virus that causes one of the most common sexually transmitted diseases: human papillomavirus, or HPV. There are more than 150 different types of HPVs, but only a small group are known to cause cervical cancer. When Lacks’ cervical cancer cells were successfully grown in a petri dish in 1951, scientists now had a source of cost-effective and easy-to-use cells that expanded their ability to conduct research. From polio and COVID-19 vaccines to cancer research and sequencing the human genome, HeLa cells have played an enormous role in many scientific discoveries and advancements. Henrietta Lacks’ story is also an ongoing bioethics case, because these cells were taken from her during a routine cervical cancer biopsy that was then given to researchers without her consent, as was common practice at the time. As a cancer researcher who uses HeLa cells in my everyday work, even I sometimes find it hard to believe.

Post cover
Image courtesy of "Pique Newsmagazine"

Quebec to use HPV test to screen for cervical cancer, replacing Pap ... (Pique Newsmagazine)

MONTREAL — Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear.

The Health Department says it's currently up to doctors to recommend Pap smears during routine medical visits and that the tests are not administered with any regularity across the province. The Health Department says the province will systematically offer HPV testing for cervical cancer screening to all women aged 25 to 65, every five years. MONTREAL — Quebec says it will start using human papillomavirus tests as its primary screening tool for cervical cancer, replacing the Pap smear.

Post cover
Image courtesy of "OI Canadian"

Pap test replaced by HPV detection test (OI Canadian)

Screening for cancer of the cervix, a disease caused in more than 99% of cases by the human papillomavirus (HPV), will now consist of detecting the presence of ...

In 2012, approximately 70% of Quebec women aged 18 to 69 had had a Pap test. Details, terms and implementation steps for this new test will be announced in the coming months. Health Minister Christian Dubé will announce on Tuesday that this unpopular cervical cancer screening procedure will be phased out and replaced by a simple swab.

Post cover
Image courtesy of "CKPGToday.ca"

Quebec to use HPV test to screen for cervical cancer, replacing Pap ... (CKPGToday.ca)

MONTREAL - Quebec says it will start using human papillomavirus tests as its primary screening tool for cervic...

Single LR-HPV infection exists in minority HSIL patients. | IDR (Dove Medical Press)

The status of human papillomavirus infections in women in Yunnan in the south of China and their correlation with grade of cervical intraepithelial ...

Single subtype infection and multiple subtype infection have different impacts on CIN. Kim et al 20 compared the HPV genotypes of 236 patients with a multiple subtype infection and 180 patients with a single subtype infection, and they found that the correlation between multiple subtype infections and HSIL was closer than that between a single subtype infection and HSIL. The infections were also seen to last longer in patients with multiple subtype infections than in patients with a single subtype infection. The three subtypes of HR-HPV with the highest infection rate were HPV16, HPV52 and HPV58. HPV43 is the main subtype of LR-HPV. There was no correlation between ethnicity and single or multiple infections in different CIN groups. The main HR-HPV subtypes were 52 (25.3%), 58 (16.1%) and 16 (16.1%) in the LSIL group, and 16 (37.8%), 58 (15.4%), and 52 (11.2%) in the HSIL group. In the LSIL group, there were 39 cases of single infection and 15 cases of multiple infection in han nationality, 19 cases of single infection and 6 cases of multiple infection in minority nationality, χ2= 0.0063, P > 0.05, the difference was not statistically significant. The main LR-HPV subtypes were 43 (23.8%), 42 (19.0%), and 40 (4.8%) in the LSIL group, and 43 (29.4%), 81 (29.4%), and 11 (17.6%) in the HSIL group. This is related to the different susceptibility and clearance rates of different types of HPV in different regions, different nationalities and different physical hosts. Single and multiple infection rates of different ages in LSIL group showed no significant difference (X2 = 2.797, P = 0.258). There was also no significant difference in single and multiple infection rates of different ages in HSIL group (X2 = 5.037, P = 0.081) ( Table 2). In the LSIL group, there were 27 patients (34%) with a single subtype infection in the age range from 30 to 45 years, which was the age group with the highest proportion of single-type infections, and in the HSIL group, there were 83 patients (41%) with a single subtype infection in the age range from 30 to 45 years old, which was also the main single subtype infection age group. In HISL group, there were 131 cases of single infection and 41 cases of multiple infection in han nationality, 22 cases of single infection and 8 cases of multiple infection in minority nationality (χ2=0.0105, P>0.05). It showed that there was no significant difference between ethnic group and single or multiple infection in different CIN groups ( Table 4). However, it should be noted that two ethnic HSIL patients had a single LR-HPV infection. Twelve percent of HSIL patients were <30 years old, and there were 60 patients aged 30–45 years in the HSIL group, accounting for 58% of the group, and this was the age group with a high incidence. Immunohistochemical P16 expression was block-positive reactivity in HSIL patients ( Figure 2), Ki67 index >30% ( Figure 3). Morphological LSIL patients showed negative or mottled expression of P16 and Ki67 index <30%. 2, 3 Human papillomavirus (HPV) infections are known to be closely related to cervical precancerous lesions and cervical cancer, and the main cause of cervical cancer is a persistent infection of high-risk HPV (HR-HPV). 4, 5 Cervical intraepithelial neoplasia (CIN) is a precancerous disease.

Explore the last week